Shares of International Biotechnology (LON:IBT - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 691.15 ($8.73) and traded as high as GBX 720 ($9.10). International Biotechnology shares last traded at GBX 712 ($9.00), with a volume of 19,137 shares traded.
International Biotechnology Stock Performance
The firm has a market cap of £258.63 million, a price-to-earnings ratio of 6.87 and a beta of 0.21. The stock has a 50-day moving average of GBX 702.28 and a 200-day moving average of GBX 691.58.
International Biotechnology Increases Dividend
The firm also recently disclosed a dividend, which was paid on Friday, January 24th. Stockholders of record on Thursday, December 19th were issued a GBX 15.56 ($0.20) dividend. The ex-dividend date of this dividend was Thursday, December 19th. This is an increase from International Biotechnology's previous dividend of $14.50. This represents a dividend yield of 2.21%. International Biotechnology's dividend payout ratio (DPR) is 27.67%.
Insider Buying and Selling
In related news, insider Alexa Henderson purchased 6,996 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was purchased at an average cost of GBX 711 ($8.98) per share, for a total transaction of £49,741.56 ($62,844.67). Also, insider Katherine Cornish-Bowden purchased 1,500 shares of the stock in a transaction on Tuesday, December 17th. The shares were bought at an average cost of GBX 713 ($9.01) per share, for a total transaction of £10,695 ($13,512.32). 4.18% of the stock is currently owned by corporate insiders.
International Biotechnology Company Profile
(
Get Free Report)
The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Featured Articles
Before you consider International Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.
While International Biotechnology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
